Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice

Blood-based biomarker testing of insulin resistance (IR) and beta cell dysfunction may identify diabetes risk earlier than current glycemia-based approaches. This retrospective cohort study assessed 1,687 US patients at risk for cardiovascular disease (CVD) under routine clinical care with a compreh...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Varvel, Stephen A., Voros, Szilard, Thiselton, Dawn L., Pottala, James V., Dall, Tara, Warnick, G. Russell, McConnell, Joseph P., Ghaedi, Leila, Sasinowski, Maciek, Graham, Timothy
Format: Artigo
Langue:Inglês
Publié: Springer US 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137169/
https://ncbi.nlm.nih.gov/pubmed/25070680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-014-9577-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires